Search research articles
Contact Us
Filters
Showing results (101-110 of 139) with videos related to
Page
of 14
Sort By:
British Journal of Anaesthesia
|
December 1, 1981
Controlled-release morphine tablets. A double-blind trial in dental surgery patients
G W Hanks, N M Rose, G W Aherne, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Evaluation of immunohistochemical staining and activity of thymidylate synthase in cell lines
C L Van der Wilt, K Smid, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
The effect of food on the oral administration of 6-mercaptopurine
N K Burton, M J Barnett, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients
P Beale, I Judson, J Hanwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusion
V J Harvey, M L Slevin, G W Aherne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1983
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid
M L Slevin, E M Piall, G W Aherne, et al.
Pain
|
April 1, 1990
CSF concentrations of morphine-6-glucuronide after oral administration of morphine
P Poulain, Moran A Ribon, G W Hanks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues
S J Welsh, J Titley, L Brunton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Balb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicity
S J Clarke, D C Farrugia, G W Aherne, et al.
British Journal of Cancer
|
December 4, 1998
The renal effects of the water-soluble, non-folylpolyglutamate synthetase-dependent thymidylate synthase inhibitor ZD9331 in mice
M I Walton, F Mitchell, G W Aherne, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 139) with videos related to
Sort By:
Page
of 14
British Journal of Anaesthesia
|
December 1, 1981
Controlled-release morphine tablets. A double-blind trial in dental surgery patients
G W Hanks, N M Rose, G W Aherne, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Evaluation of immunohistochemical staining and activity of thymidylate synthase in cell lines
C L Van der Wilt, K Smid, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
The effect of food on the oral administration of 6-mercaptopurine
N K Burton, M J Barnett, G W Aherne, et al.
Cancer Chemotherapy and Pharmacology
|
June 10, 1998
Metabolism, excretion and pharmacokinetics of a single dose of [14C]-raltitrexed in cancer patients
P Beale, I Judson, J Hanwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusion
V J Harvey, M L Slevin, G W Aherne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1983
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid
M L Slevin, E M Piall, G W Aherne, et al.
Pain
|
April 1, 1990
CSF concentrations of morphine-6-glucuronide after oral administration of morphine
P Poulain, Moran A Ribon, G W Hanks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues
S J Welsh, J Titley, L Brunton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2000
Balb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicity
S J Clarke, D C Farrugia, G W Aherne, et al.
British Journal of Cancer
|
December 4, 1998
The renal effects of the water-soluble, non-folylpolyglutamate synthetase-dependent thymidylate synthase inhibitor ZD9331 in mice
M I Walton, F Mitchell, G W Aherne, et al.
Page
of 14